Work

Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program

Year: 2003

Type: review

Source: American Heart Journal

DOI: 10.1016/s0002-8703(03)00398-3

Authors: Matthew R Weir, Rhoda S Sperling, Alise Reicin, Barry J Gertz

Institutions: University of Maryland Medical Center, Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Inflammatory mediators and NSAID effects

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2154476123

FWCI: 1.947

Cites: 96

Cited by: 121

Related to: 10